Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)
Clinical trial NCT05304364 · COMPLETED
Trial details
- NCT number
- NCT05304364
- Sponsor
- Delpor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2022-10-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.